Milae Bioresources미래생명자원
218150 · KOSDAQ · ₩218150 · 미래생명자원
₩1,687▼ ₩10 (0.59%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩68B | ₩62B | ₩60B | ₩76B | ₩67B |
| Cost of sales | ₩57B | ₩54B | ₩52B | ₩66B | ₩58B |
| Gross profit | ₩10B | ₩8B | ₩8.2B | ₩9.5B | ₩8.5B |
| Operating income | −₩1.4B | ₩184M | ₩20M | ₩1.6B | ₩1.9B |
| Net income | −₩3B | −₩420M | ₩359M | ₩878M | ₩1.1B |
| Net income to shareholders | −₩3.3B | −₩433M | ₩441M | ₩963M | ₩1.1B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩59B | ₩64B | ₩52B | ₩56B | ₩55B |
| Current assets | ₩32B | ₩33B | ₩38B | ₩42B | ₩42B |
| Cash and equivalents | ₩6.1B | ₩4.8B | ₩2B | ₩7.6B | ₩18B |
| Total liabilities | ₩16B | ₩18B | ₩7.4B | ₩15B | ₩22B |
| Current liabilities | ₩15B | ₩17B | ₩7.1B | ₩15B | ₩7.4B |
| Borrowings | ₩9.1B | ₩11B | ₩3.3B | ₩11B | ₩17B |
| Total equity | ₩43B | ₩46B | ₩44B | ₩41B | ₩33B |
| Shareholders' equity | ₩40B | ₩44B | ₩44B | ₩41B | ₩33B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩4.4B | −₩966M | ₩3.2B | ₩1.2B | ₩3B |
| Capital spending | ₩401M | ₩103M | ₩627M | ₩486M | ₩530M |
| Free cash flow | ₩4B | −₩1.1B | ₩2.6B | ₩706M | ₩2.5B |
Consolidated where available. Amounts in won.
Also known as: Milae Bioresources / 미래생명자원 / 218150 / KRX:218150
Source: KRX statistical information